Clinical Trial Update: Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating cryoablation with tislelizumab and lenvatinib in previously treated gastric cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastric Cancer with Liver Metastases

Drugs mentioned

• Lenvatinib (lenvatinib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer Metastatic to Liver | Phase 2 | Status: UNKNOWN